3538-74-7

Usage

Uses

Used in Pharmaceutical Industry:
AKOS B014946 is used as a progestin for the development of hormone replacement therapies, contraceptive medications, and treatments for endocrine disorders. Its potential applications in this industry are driven by its ability to mimic the effects of progesterone, a key hormone in the female reproductive system.
Used in Hormone Replacement Therapies:
AKOS B014946 is used as a hormone replacement agent to address hormonal imbalances, particularly in postmenopausal women. It helps in managing symptoms associated with menopause and supports overall reproductive health.
Used in Contraceptive Medications:
AKOS B014946 is used as a contraceptive agent to prevent pregnancy by interfering with the normal menstrual cycle and ovulation process. Its progestin properties make it a valuable component in the development of various contraceptive formulations.
Used in Treatments for Endocrine Disorders:
AKOS B014946 is used as a therapeutic agent for treating endocrine disorders related to hormonal imbalances. Its ability to modulate progesterone levels can help in managing conditions such as polycystic ovary syndrome (PCOS) and other hormonal imbalances.
Used in Anti-inflammatory and Neuroprotective Research:
AKOS B014946 is being studied for its potential anti-inflammatory and neuroprotective properties. Its ability to modulate immune responses and protect neural cells makes it a promising candidate for further research in the development of treatments for inflammatory and neurodegenerative diseases.

InChI:InChI=1/C10H14N2O/c1-2-9(10(13)12-11)8-6-4-3-5-7-8/h3-7,9H,2,11H2,1H3,(H,12,13)